Primary Prevention of Cardiovascular Disease in Diabetes Mellitus.
Authors Newman JD, Schwartzbard AZ, Weintraub HS, Goldberg IJ, Berger JS
Submitted By Jonathan Newman on 8/29/2017
Status Published
Journal Journal of the American College of Cardiology
Year 2017
Date Published 8/1/2017
Volume : Pages 70 : 883 - 893
PubMed Reference 28797359
Abstract Type 2 diabetes mellitus (T2D) is a major risk factor for cardiovascular disease
(CVD), the most common cause of death in T2D. Yet, <50% of U.S. adults with T2D
meet recommended guidelines for CVD prevention. The burden of T2D is increasing:
by 2050, approximately 1 in 3 U.S. individuals may have T2D, and patients with
T2D will comprise an increasingly large proportion of the CVD population. The
authors believe it is imperative that we expand the use of therapies proven to
reduce CVD risk in patients with T2D. The authors summarize evidence and
guidelines for lifestyle (exercise, nutrition, and weight management) and CVD
risk factor (blood pressure, cholesterol and blood lipids, glycemic control, and
the use of aspirin) management for the prevention of CVD among patients with
T2D. The authors believe appropriate lifestyle and CVD risk factor management
has the potential to significantly reduce the burden of CVD among patients with